Challenges/barriers of deprescribing during COVID-19

Jatau, Abubakar Ibrahim, Sha'aban, Abubakar ORCID: https://orcid.org/0000-0002-5491-9851 and Auwal, Fatima 2023. Challenges/barriers of deprescribing during COVID-19. Elbeddini, Ali, ed. Deprescribing and Polypharmacy in an Aging Population, Elsevier, pp. 123-137. (10.1016/B978-0-323-99138-4.00005-9)

Preview

PDF - Accepted Post-Print Version Download (238kB) | Preview

Abstract

The COVID-19 pandemic has affected all aspects of life significantly, including healthcare systems. It is therefore important for us to use medications effectively to minimize hospitalizations and strain on the healthcare system. Deprescribing could present an opportunity for reducing drug-related harm and contact between patient and healthcare professionals, as well as minimizing the unnecessary use of medications at risk of short supply. Although high-quality evidence from randomized studies is required to prove the benefits of deprescribing, available data thus far has demonstrated that deprescribing could optimize the use of medications and prevent risk of contracting COVID-19 infection. This chapter provides an overview of challenges unique to the COVID-19 pandemic, namely, the increased demands on the healthcare system. Furthermore, the chapter explores deprescribing practices during the pandemic as well as strategies to address barriers to deprescribing.

Item Type:	Book Section
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
ISBN:	9780323991384
Date of First Compliant Deposit:	8 November 2024
Date of Acceptance:	16 February 2023
Last Modified:	09 Dec 2024 11:00
URI:	https://orca.cardiff.ac.uk/id/eprint/173782

Actions (repository staff only)

Edit Item